Gene · 8106
Papers1,471
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,471
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The polyA tail facilitates splicing of last introns with weak 3' splice sites via PABPN1. | EMBO Rep | 2023 | 37661812 | PubTator, text mining | PubMed |
| PROCEEDINGS OF THE XXIII CONGRESS OF THE ITALIAN ASSOCIATION OF MYOLOGY: PadovaJune 8-10, 2023. | Acta Myol | 2023 | 37650038 | PubTator, text mining | PubMed |
| m6A-Mediated Biogenesis of circDDIT4 Inhibits Prostate Cancer Progression by Sequestrating ELAVL1/HuR. | Mol Cancer Res | 2023 | 37647111 | PubTator, text mining | PubMed |
| Four types of adenine-related RNA modification writers -mediated molecular subtypes contribute to predicting clinical outcomes and treatment options in bladder cancer. | Front Immunol | 2023 | 37638051 | PubTator, text mining | PubMed |
| TERRA beyond cancer: the biology of telomeric repeat-containing RNAs in somatic and germ cells. | Front Aging | 2023 | 37636218 | PubTator, text mining | PubMed |
| The Role and Applications of Exosomes in Gynecological Cancer: A Review. | Cell Transplant | 2023 | 37632354 | PubTator, text mining | PubMed |
| Virus Infection and mRNA Nuclear Export. | Int J Mol Sci | 2023 | 37628773 | PubTator, text mining | PubMed |
| Circ_0067934: a circular RNA with roles in human cancer. | Hum Cell | 2023 | 37592109 | PubTator, text mining | PubMed |
| Complementary analysis of proteome-wide proteomics reveals changes in RNA binding protein-profiles during prostate cancer progression. | Cancer Rep (Hoboken) | 2023 | 37591798 | PubTator, text mining | PubMed |
| Going circular: history, present, and future of circRNAs in cancer. | Oncogene | 2023 | 37587333 | PubTator, text mining | PubMed |
| Oculopharyngeal muscular dystrophy mutations link the RNA-binding protein HNRNPQ to autophagosome biogenesis. | Aging Cell | 2023 | 37559347 | PubTator, text mining | PubMed |
| Choked: A Case Report of Oculopharyngeal Muscular Dystrophy Mimicking Hypothyroidism From the Philippines. | Cureus | 2023 | 37519616 | PubTator, text mining | PubMed |
| Functions of Circular RNA in Human Diseases and Illnesses. | Noncoding RNA | 2023 | 37489458 | PubTator, text mining | PubMed |
| Alternative Splicing of lncRNAs From SNHG Family Alters snoRNA Expression and Induces Chemoresistance in Hepatoblastoma. | Cell Mol Gastroenterol Hepatol | 2023 | 37478905 | PubTator, text mining | PubMed |
| Abnormal phase separation of biomacromolecules in human diseases. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37475546 | PubTator, text mining | PubMed |
| PABPN1 promotes clear cell renal cell carcinoma progression by suppressing the alternative polyadenylation of SGPL1 and CREG1. | Carcinogenesis | 2023 | 37452741 | PubTator, text mining | PubMed |
| The Continuous Adaptive Challenge Played by Arboviruses: An In Silico Approach to Identify a Possible Interplay between Conserved Viral RNA Sequences and Host RNA Binding Proteins (RBPs). | Int J Mol Sci | 2023 | 37446229 | PubTator, text mining | PubMed |
| Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy. | Int J Mol Sci | 2023 | 37445672 | PubTator, text mining | PubMed |
| SRSF1 induces glioma progression and has a potential diagnostic application in grading primary glioma. | Oncol Lett | 2023 | 37427339 | PubTator, text mining | PubMed |
| PABPN1 aggregation is driven by Ala expansion and poly(A)-RNA binding, leading to CFIm25 sequestration that impairs alternative polyadenylation. | J Biol Chem | 2023 | 37422193 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8106/papers?page=6